Association between Polymorphisms in DNA Repair and Inflammatory Response Genes and Ctcae 3.0 Grade 2 or Worse Esophagitis Induced by Neoadjuvant Platinum-based Chemotherapy and Thoracic Radiotherapy

被引:0
|
作者
Zhang, G. [1 ]
Fan, M. [1 ]
Jiang, G. [1 ]
Fu, X. [1 ]
Chen, J. [1 ]
Xie, L. [1 ]
Xu, X. [1 ]
机构
[1] Fudan Univ Shanghai Canc Hosp, Shanghai, Peoples R China
关键词
D O I
10.1016/j.ijrobp.2010.07.485
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S200 / S201
页数:2
相关论文
共 32 条
  • [21] Evaluation of Prediction of Polymorphisms of DNA Repair Genes on the Efficacy of Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer: A Network Meta-Analysis
    Yu, Shao-Nan
    Liu, Gui-Feng
    Li, Xue-Feng
    Fu, Bao-Hong
    Dong, Li-Xin
    Zhang, Shu-Hua
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2017, 118 (12) : 4782 - 4791
  • [22] Association of ABCC2 polymorphisms with platinum-based chemotherapy response and severe toxicity in non-small cell lung cancer patients
    Han, Baohui
    Gao, Ge
    Wu, Wenting
    Gao, Zhiqiang
    Zhao, Xueying
    Li, Ling
    Qiao, Rong
    Chen, Hongyan
    Wei, Qingyi
    Wu, Jinchang
    Lu, Daru
    LUNG CANCER, 2011, 72 (02) : 238 - 243
  • [23] Association Between Polymorphisms of ERCC1 and XPD and Clinical Response to Platinum-Based Chemotherapy in Advanced Non-Small Cell Lung Cancer
    Li, Fan
    Sun, Xinchen
    Sun, Ning
    Qin, Shukui
    Cheng, Hongyan
    Feng, Jifeng
    Chen, Baoan
    Cheng, Lu
    Lu, Zuhong
    Ji, Jiazhong
    Zhou, Yingfeng
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2010, 33 (05): : 489 - 494
  • [24] SINGLE NUCLEOTIDE POLYMORPHISMS IN DNA REPAIR GENE ERCC1 PREDICT CLINICAL RESPONSE TO PLATINUM-BASED CHEMOTHERAPY IN NON-SMALL CELL LUNG CANCER
    Xu, Lin
    Ren, Binhui
    Li, Ming
    Yang, Xin
    Jiang, Feng
    Yin, Rong
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1303 - S1304
  • [25] Association of DNA base excision repair genes (OGG1, APE1 and XRCC1) polymorphisms with outcome to platinum-based chemotherapy in advanced nonsmall-cell lung cancer patients
    Peng, Yu
    Li, Zheng
    Zhang, Shiheng
    Xiong, Yanli
    Cun, Yanping
    Qian, Chengyuan
    Li, Mengxia
    Ren, Tao
    Xia, Lei
    Cheng, Yi
    Wang, Dong
    INTERNATIONAL JOURNAL OF CANCER, 2014, 135 (11) : 2687 - 2696
  • [26] The Association between COX-2 Polymorphisms and Hematologic Toxicity in Patients with Advanced Non-Small-Cell Lung Cancer Treated with Platinum-Based Chemotherapy
    Zhou, Fei
    Gao, Guanghui
    Ren, Shengxiang
    Li, Xuefei
    He, Yayi
    Zhou, Caicun
    PLOS ONE, 2013, 8 (04):
  • [27] The association between COX-2 polymorphisms and hematologic toxicity in patients with advanced non-small-cell lung cancer treated with platinum-based chemotherapy
    Fei, Zhou
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [28] Association of Bcl2 family gene polymorphisms with response to and toxicity of platinum-based chemotherapy in non-small-cell lung cancer patients in a Chinese population
    Qian, Ji
    Wu, Qi Han
    Lu, Da Ru
    Wei, Qing Yi
    CANCER RESEARCH, 2011, 71
  • [29] Polymorphisms in microRNA let-7 binding sites of the HIF1AN and CLDN12 genes can predict pathologic complete response to taxane- and platinum-based neoadjuvant chemotherapy in breast cancer
    Du, Yueyao
    Zhou, Liheng
    Lin, Yanping
    Yin, Kai
    Yin, Wenjin
    Lu, Jinsong
    ANNALS OF TRANSLATIONAL MEDICINE, 2019, 7 (07)
  • [30] The association between the ERCC1/2 polymorphisms and the clinical outcomes of the platinum-based chemotherapy in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis
    Yang, Yanlong
    Xian, Lei
    TUMOR BIOLOGY, 2014, 35 (04) : 2905 - 2921